Product Console

Pilot programs healthcare buyers can fund

Move from workflow pain to a decision-grade SCRIMED pilot.

Choose the right level of commitment: quick workflow assessment, synthetic pilot evaluation, protected enterprise pilot, or AI governance and interoperability readiness, each with deliverables, buyer inputs, success metrics, and retained production boundaries.

Statusbuyer-ready-synthetic-evaluations
Programs4
Sellable now3
Protected pilots1
Price bands4

From demo to funded pilot

investor-ready-synthetic-commercial-proof

Use /pilot-demo-commercial-readiness before buyer calls so each demo resolves to one pilot package, price band, proof asset list, intake route, and retained boundary; then use protected pilot onboarding packets, activation proof packets, and session proof packets to support enterprise security, privacy, legal, and budget review.

step 1

Public product demo inspection

SCRIMED demos and pilot programs are governed synthetic evaluations for enterprise buyers. They do not ingest live PHI, diagnose, treat, submit payer transactions, contact patients, mutate production records, or autonomously execute clinical care.

Inspect conversion surface
step 2

Workflow Intelligence Assessment

SCRIMED demos and pilot programs are governed synthetic evaluations for enterprise buyers. They do not ingest live PHI, diagnose, treat, submit payer transactions, contact patients, mutate production records, or autonomously execute clinical care.

Inspect conversion surface
step 3

Synthetic Pilot Evaluation

SCRIMED demos and pilot programs are governed synthetic evaluations for enterprise buyers. They do not ingest live PHI, diagnose, treat, submit payer transactions, contact patients, mutate production records, or autonomously execute clinical care.

Inspect conversion surface
step 4

Protected Enterprise Atlas Pilot

SCRIMED demos and pilot programs are governed synthetic evaluations for enterprise buyers. They do not ingest live PHI, diagnose, treat, submit payer transactions, contact patients, mutate production records, or autonomously execute clinical care.

Inspect conversion surface
step 5

Governed annual platform expansion

SCRIMED demos and pilot programs are governed synthetic evaluations for enterprise buyers. They do not ingest live PHI, diagnose, treat, submit payer transactions, contact patients, mutate production records, or autonomously execute clinical care.

Inspect conversion surface

Pilot catalog

Every program defines what the buyer funds, what SCRIMED delivers, and what decision comes next.

sellable-now · 60 days

60-Day Governed Automation Pilot

Enterprise healthcare teams validating workflow value, trust, and human-review design before integration

Run a selected workflow through deterministic synthetic evidence, AgentOS orchestration, TrustQA, observability, and executive review.
  • Recommended synthetic-pilot range: $125k-$350k; $350k-$500k when multiple workflows, custom diligence, or executive proof packets expand scope
  • 5 deliverables
  • 4 success metrics
  • /pilot?offer=synthetic-pilot-evaluation
protected-pilot · 90 days

90-Day Enterprise Atlas Pilot

Health systems, payers, governments, and enterprise operators preparing controlled deployment

Design the tenant, governance, interoperability, audit, runtime safety, and value model required for a controlled enterprise deployment.
  • Recommended protected-pilot range: $400k-$1.25M; $1.25M-$2M+ for multi-site, sandbox-planning, or buyer-specific protected diligence scope
  • 5 deliverables
  • 4 success metrics
  • /pilot?offer=clinical-operations-automation-blueprint

Pricing alignment

Pilot pricing now follows one market-informed ladder from free demos to enterprise operating licenses.

aligned tier

Workflow Intelligence Assessment

$25k-$75k standard; $12.5k-$25k mission clinic access path for one no-PHI workflow; $75k-$150k for multi-workflow enterprise assessment.

Individual scribe subscriptions are cheap, but enterprise assessment value sits in workflow redesign, governance, interoperability, and executive decision support.
  • Cap workflows, meetings, artifacts, and review cycles; discount only by reducing scope.
  • A fast, finite way to decide whether a full pilot is worth funding.
aligned tier

Synthetic Pilot Evaluation

$125k-$350k standard for 45-90 days; $350k-$500k when multiple workflows, extra diligence, or executive proof packets are included.

Enterprise AI workflow pilots should sit well above seat-based scribe tools while staying below production integration commitments.
  • Limit workflow count and evidence cadence; separately price custom data modeling, legal/security packet labor, and implementation planning.
  • A decision-grade enterprise evaluation before the buyer funds protected production work.
aligned tier

Protected Enterprise Pilot

$400k-$1.25M for 90-180 days; $1.25M-$2M+ when buyer-specific protected diligence, sandbox planning, or multi-site scope expands.

Redox and enterprise AI vendors use custom pricing because integration, security, governance, reliability, and implementation scope drive cost.
  • Separate license, services, support, connectors, evidence-room labor, customer success, and change orders.
  • A controlled enterprise activation path that prepares production without pretending production is already approved.
aligned tier

Enterprise Operating License

$1.5M-$6M annual for initial enterprise operating layer; $6M-$12M+ for multi-department or multi-region expansion.

Ambience, Suki, Redox, and similar enterprise motions compete on workflow breadth, EHR adjacency, trust, uptime, data exchange, and measurable operational outcomes.
  • Annual license is separate from implementation services, model usage, support tier, connector work, and continuous review retainer.
  • Start with validated workflows, then expand as evidence, authority, and operational coverage mature.